X Inactivation and Somatic Cell Selection Rescue Female Mice Carrying a Piga-Null Mutation

Total Page:16

File Type:pdf, Size:1020Kb

X Inactivation and Somatic Cell Selection Rescue Female Mice Carrying a Piga-Null Mutation Proc. Natl. Acad. Sci. USA Vol. 96, pp. 7479–7483, June 1999 Medical Sciences X inactivation and somatic cell selection rescue female mice carrying a Piga-null mutation (Cre/loxPyglycosyl phosphatidylinositolyXp22yparoxysmal nocturnal hemoglobinuria) PETER KELLER*, GABI TREMML†,VITTORIO ROSTI†, AND MONICA BESSLER*‡ *Division of Hematology, Departments of Internal Medicine and Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO 63110; and †Department of Human Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021 Edited by Ernest Beutler, The Scripps Research Institute, La Jolla, CA, and approved May 6, 1999 (received for review March 22, 1999) ABSTRACT A somatic mutation in the X linked PIGA some (‘‘Ohno’s law;’’ ref. 8), the murine Piga maps to X-F3/4. gene is responsible for the deficiency of glycosyl phosphati- Piga gene inactivation in murine embryonic stem (ES) cells dylinositol (GPI)-anchored proteins on blood cells from pa- followed by blastocyst injection is associated with a high rate tients with paroxysmal nocturnal hemoglobinuria. No inher- of early embryonic lethality and low chimerism in surviving ited form of GPI-anchor deficiency has been described. Be- animals (9, 10). Female mice heterozygous for a mutant Piga cause conventional Piga gene knockout is associated with high gene have never been obtained. To study the consequences of embryonic lethality in chimeric mice, we used the Cre/loxP a nonfunctional Piga gene and to address the issue of a system. We generated mice in which two loxP sites flank part maternally inherited Piga mutation, we generated mice carry- of Piga exon 2. After crossbreeding with female mice of the ing a Piga mutation using Cre/loxP-controlled DNA recombi- EIIa-cre strain, the floxed allele undergoes Cre-mediated nation (11). High efficiency of Piga gene recombination was recombination with high efficiency during early embryonic obtained by targeting Piga gene inactivation directly to the development. Because of X chromosome inactivation, female preimplantation female embryo. Because of X inactivation, offspring are mosaic for cells that express or lack GPI-linked newborn female mice are mosaic, with cells that express or lack proteins. Analysis of mosaic mice showed that in heart, lung, GPI-linked proteins. To assess the importance of PIGA in kidney, brain, and liver, mainly wild-type Piga is active, different organs, we determined the relative contribution of suggesting that these tissues require GPI-linked proteins. The cells expressing or lacking GPI-linked proteins. Female mice salient exceptions were spleen, thymus, and red blood cells, that had high efficiency of Piga gene recombination enabled us which had almost equal numbers of cells expressing the to further investigate the possibility of an inherited Piga gene wild-type or the recombined allele, implying that GPI-linked mutation. proteins are not essential for the derivation of these tissues. PIGA(2) cells had no growth advantage, suggesting that other MATERIALS AND METHODS factors are needed for their clonal dominance in patients with Production of the lox-Piga-lacZ Mice. The production of the paroxysmal nocturnal hemoglobinuria. lox-Piga-lacZ mice has been described in detail previously (12). In brief: two loxP sites were introduced by homologous re- The gene PIGA (phosphatidylinositol glycan class A) encodes combination into the Piga locus of 129SV-derived ES cells CJ7, a subunit of the a1–6-N-acetylglucosaminyltransferase com- flanking 662 bp of exon 2 and 1.6 kb of the adjoining intron 2. plex, an enzyme essential for the biosynthesis of glycosyl In addition, the coding region of the lacZ gene was inserted phosphatidylinositol (GPI) anchors (1, 2). In paroxysmal noc- into intron 2 in such a way that in the lox-Piga-lacZ configu- turnal hemoglobinuria (PNH), an acquired hemolytic anemia, ration (floxed Piga gene), LacZ is not expressed and does not a somatic mutation in the PIGA gene causes a proportion of interfere the function of PIGA. However, after Cre-mediated blood cells to be deficient in all GPI-linked molecules (3, 4). Piga recombination (lox-DPiga-lacZ), lacZ will find itself in- PIGA maps to the X chromosome (4, 5). Its location on the X frame 39 of the translation start of the Piga gene and therefore chromosome explains why a single mutation is sufficient to will be driven by the endogenous Piga promoter. The structure abrogate the expression of GPI-linked proteins. Because of X of wild-type (wt) Piga, lox-Piga-lacZ, and Lox-DPiga-lacZ are chromosome inactivation in female cells, both male and female shown in Fig. 1A. ES cells carrying the lox-Piga-lacZ gene were cells contain one single active Piga gene. In PNH, the mutation injected into C57BL/6 blastocysts to generate chimeric mice. is thought to occur in a hematopoietic stem cell, because Chimeric males were crossbred with C57BL/6 female mice. GPI-deficient cells are found in all blood cell lineages (for Lox-Piga-lacZ showed the expected X linked transmission review, see ref. 6). Although the mutations account for the pattern. Hemizygous lox-Piga-lacZ males were obtained in the deficiency of GPI-linked proteins on the affected blood cells, N2 generation. it is not clear that mutations of the PIGA gene cause the clonal FVB/NJ mice homozygous for the EIIa-cre transgene (EIIa- expansion that enables GPI-anchor-deficient blood cells to cre(1/1) mice) were generously provided by Heiner Westphal become the dominant blood cell population in patients with (National Institutes of Health, Bethesda, MD; ref. 13). Lox- PNH. Piga-lacZ mice were crossbred with EIIa-cre(1/1) mice as GPI-linked proteins are found in almost every tissue and indicated. The lox-Piga-lacZ/EIIa-cre offspring therefore had a serve many different functions (7). An inherited form of mixed genetic background. complete GPI-anchor deficiency has not been reported and is probably not compatible with life. Conforming to the evolu- This paper was submitted directly (Track II) to the Proceedings office. tionary conservation of synteny of the mammalian X chromo- Abbreviations: PIGA, phosphatidylinositol glycan class A; PIGA refers to the human gene, Piga to the murine gene, and PIGA to the gene The publication costs of this article were defrayed in part by page charge product of either species; ES, embryonic stem; PNH, paroxysmal nocturnal hemoglobinuria; GPI, glycosyl phosphatidylinositol; wt, wild payment. This article must therefore be hereby marked ‘‘advertisement’’ in type. accordance with 18 U.S.C. §1734 solely to indicate this fact. ‡To whom reprint requests should be addressed. e-mail: mbessler@ PNAS is available online at www.pnas.org. im.wustl.edu. 7479 Downloaded by guest on September 25, 2021 7480 Medical Sciences: Keller et al. Proc. Natl. Acad. Sci. USA 96 (1999) 0.7% agarose gels at 38 V for 60–72 hours and transferred to Hybond-N nylon membranes (Amersham Pharmacia) by using Southern blotting. The filters were hybridized to a SacII– BamHI DNA probe including exon 1 (Sac-Bam). The band intensity ratios were defined with a phosphoimager (Molecular Imager System GS-525, Bio-Rad) by using MOLECULAR ANA- LYST version 2.1.2 software (Bio-Rad). Analysis of GPI-Anchored Membrane Proteins. GPI-linked surface proteins on erythrocyte membranes were measured by using flow cytometry (FACscan, Becton Dickinson) with FITC- conjugated mAbs against CD24 (M1/69, PharMingen) (10). RESULTS Production of Mice with High Level of Piga Gene Recom- bination. To obtain high efficiency of Cre-mediated Piga gene recombination, we took advantage of the expression pattern of the EIIa promoter. Expression from the EIIa promoter in the absence of its natural transcriptional activator, the E1A gene product, is restricted to oocytes and preimplantation embryos (15). Therefore, we predicted that Cre-mediated Piga gene recombination in the early embryo will be most efficient if EIIa-cre is maternally derived. Accordingly, we crossbred hemizygous lox-Piga-lacZ(1) males with homozygous EIIa- cre(1/1) females. Thirty-one mice were born. Nineteen were FIG.1.(A) Genomic structure of wt Piga, lox-Piga-lacZ, and males, which, because of the breeding strategy, did not inherit lox-Piga-lacZ after recombination (lox-DPiga-lacZ). Two loxP sites (open arrows) and the coding region for lacZ (lacZ-box) were intro- a lox-Piga-lacZ gene. Twelve offspring were females, and all duced into the Piga locus by homologous recombination in murine ES carried a lox-Piga-lacZ and an EIIa-cre gene. The efficiency of cells (12). In the lox-Piga-lacZ configuration, PIGA function is not Cre-mediated Piga gene recombination in female offspring impaired (filled boxes), and LacZ is not expressed (open lacZ box). varied. Three had, in virtually all cells, a recombined lox-Piga- However, after Cre-mediated excision of the DNA sequences between lacZ gene (highly recombined animals), as verified by the the two lox sites Piga becomes inactivate (open Piga boxes) and LacZ absence of a lox-Piga-lacZ allele determined by PCR of tail falls under the endogenous Piga promoter and is expressed (filled lacZ DNA and Southern blot analysis (see below). In the remaining box). Restriction sites used in the methylation assay are shown. P, PstI; nine females, the extent of Cre-mediated lox-Piga-lacZ recom- S, SacII. Genomic DNA was digested with PstI (P) to obtain restriction bination varied between 0 and 95% (partially recombined fragments suitable for Southern blotting. Each PstI fragment has a different size depending on whether it is derived from the wt (7.0 kb), mice). Thus, the site-specific DNA recombination approach the lox-Piga-lacZ (10.4 kb), or the lox-DPiga-lacZ (8.1 kb) gene. To proved successful in generating female mice that had high- determine the extent of methylation DNA was subsequently digested efficiency Cre-mediated Piga gene recombination.
Recommended publications
  • Downloaded from [266]
    Patterns of DNA methylation on the human X chromosome and use in analyzing X-chromosome inactivation by Allison Marie Cotton B.Sc., The University of Guelph, 2005 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY in The Faculty of Graduate Studies (Medical Genetics) THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver) January 2012 © Allison Marie Cotton, 2012 Abstract The process of X-chromosome inactivation achieves dosage compensation between mammalian males and females. In females one X chromosome is transcriptionally silenced through a variety of epigenetic modifications including DNA methylation. Most X-linked genes are subject to X-chromosome inactivation and only expressed from the active X chromosome. On the inactive X chromosome, the CpG island promoters of genes subject to X-chromosome inactivation are methylated in their promoter regions, while genes which escape from X- chromosome inactivation have unmethylated CpG island promoters on both the active and inactive X chromosomes. The first objective of this thesis was to determine if the DNA methylation of CpG island promoters could be used to accurately predict X chromosome inactivation status. The second objective was to use DNA methylation to predict X-chromosome inactivation status in a variety of tissues. A comparison of blood, muscle, kidney and neural tissues revealed tissue-specific X-chromosome inactivation, in which 12% of genes escaped from X-chromosome inactivation in some, but not all, tissues. X-linked DNA methylation analysis of placental tissues predicted four times higher escape from X-chromosome inactivation than in any other tissue. Despite the hypomethylation of repetitive elements on both the X chromosome and the autosomes, no changes were detected in the frequency or intensity of placental Cot-1 holes.
    [Show full text]
  • 1 Supporting Information for a Microrna Network Regulates
    Supporting Information for A microRNA Network Regulates Expression and Biosynthesis of CFTR and CFTR-ΔF508 Shyam Ramachandrana,b, Philip H. Karpc, Peng Jiangc, Lynda S. Ostedgaardc, Amy E. Walza, John T. Fishere, Shaf Keshavjeeh, Kim A. Lennoxi, Ashley M. Jacobii, Scott D. Rosei, Mark A. Behlkei, Michael J. Welshb,c,d,g, Yi Xingb,c,f, Paul B. McCray Jr.a,b,c Author Affiliations: Department of Pediatricsa, Interdisciplinary Program in Geneticsb, Departments of Internal Medicinec, Molecular Physiology and Biophysicsd, Anatomy and Cell Biologye, Biomedical Engineeringf, Howard Hughes Medical Instituteg, Carver College of Medicine, University of Iowa, Iowa City, IA-52242 Division of Thoracic Surgeryh, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada-M5G 2C4 Integrated DNA Technologiesi, Coralville, IA-52241 To whom correspondence should be addressed: Email: [email protected] (M.J.W.); yi- [email protected] (Y.X.); Email: [email protected] (P.B.M.) This PDF file includes: Materials and Methods References Fig. S1. miR-138 regulates SIN3A in a dose-dependent and site-specific manner. Fig. S2. miR-138 regulates endogenous SIN3A protein expression. Fig. S3. miR-138 regulates endogenous CFTR protein expression in Calu-3 cells. Fig. S4. miR-138 regulates endogenous CFTR protein expression in primary human airway epithelia. Fig. S5. miR-138 regulates CFTR expression in HeLa cells. Fig. S6. miR-138 regulates CFTR expression in HEK293T cells. Fig. S7. HeLa cells exhibit CFTR channel activity. Fig. S8. miR-138 improves CFTR processing. Fig. S9. miR-138 improves CFTR-ΔF508 processing. Fig. S10. SIN3A inhibition yields partial rescue of Cl- transport in CF epithelia.
    [Show full text]
  • Role of RUNX1 in Aberrant Retinal Angiogenesis Jonathan D
    Page 1 of 25 Diabetes Identification of RUNX1 as a mediator of aberrant retinal angiogenesis Short Title: Role of RUNX1 in aberrant retinal angiogenesis Jonathan D. Lam,†1 Daniel J. Oh,†1 Lindsay L. Wong,1 Dhanesh Amarnani,1 Cindy Park- Windhol,1 Angie V. Sanchez,1 Jonathan Cardona-Velez,1,2 Declan McGuone,3 Anat O. Stemmer- Rachamimov,3 Dean Eliott,4 Diane R. Bielenberg,5 Tave van Zyl,4 Lishuang Shen,1 Xiaowu Gai,6 Patricia A. D’Amore*,1,7 Leo A. Kim*,1,4 Joseph F. Arboleda-Velasquez*1 Author affiliations: 1Schepens Eye Research Institute/Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, 20 Staniford St., Boston, MA 02114 2Universidad Pontificia Bolivariana, Medellin, Colombia, #68- a, Cq. 1 #68305, Medellín, Antioquia, Colombia 3C.S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114 4Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, 243 Charles St., Boston, MA 02114 5Vascular Biology Program, Boston Children’s Hospital, Department of Surgery, Harvard Medical School, 300 Longwood Ave., Boston, MA 02115 6Center for Personalized Medicine, Children’s Hospital Los Angeles, Los Angeles, 4650 Sunset Blvd, Los Angeles, CA 90027, USA 7Department of Pathology, Harvard Medical School, 25 Shattuck St., Boston, MA 02115 Corresponding authors: Joseph F. Arboleda-Velasquez: [email protected] Ph: (617) 912-2517 Leo Kim: [email protected] Ph: (617) 912-2562 Patricia D’Amore: [email protected] Ph: (617) 912-2559 Fax: (617) 912-0128 20 Staniford St. Boston MA, 02114 † These authors contributed equally to this manuscript Word Count: 1905 Tables and Figures: 4 Diabetes Publish Ahead of Print, published online April 11, 2017 Diabetes Page 2 of 25 Abstract Proliferative diabetic retinopathy (PDR) is a common cause of blindness in the developed world’s working adult population, and affects those with type 1 and type 2 diabetes mellitus.
    [Show full text]
  • An Integrated Genomic Analysis of Gene-Function Correlation on Schizophrenia Susceptibility Genes
    Journal of Human Genetics (2010) 55, 285–292 & 2010 The Japan Society of Human Genetics All rights reserved 1434-5161/10 $32.00 www.nature.com/jhg ORIGINAL ARTICLE An integrated genomic analysis of gene-function correlation on schizophrenia susceptibility genes Tearina T Chu and Ying Liu Schizophrenia is a highly complex inheritable disease characterized by numerous genetic susceptibility elements, each contributing a modest increase in risk for the disease. Although numerous linkage or association studies have identified a large set of schizophrenia-associated loci, many are controversial. In addition, only a small portion of these loci overlaps with the large cumulative pool of genes that have shown changes of expression in schizophrenia. Here, we applied a genomic gene-function approach to identify susceptibility loci that show direct effect on gene expression, leading to functional abnormalities in schizophrenia. We carried out an integrated analysis by cross-examination of the literature-based susceptibility loci with the schizophrenia-associated expression gene list obtained from our previous microarray study (Journal of Human Genetics (2009) 54: 665–75) using bioinformatic tools, followed by confirmation of gene expression changes using qPCR. We found nine genes (CHGB, SLC18A2, SLC25A27, ESD, C4A/C4B, TCP1, CHL1 and CTNNA2) demonstrate gene-function correlation involving: synapse and neurotransmission; energy metabolism and defense mechanisms; and molecular chaperone and cytoskeleton. Our findings further support the roles of these genes in genetic influence and functional consequences on the development of schizophrenia. It is interesting to note that four of the nine genes are located on chromosome 6, suggesting a special chromosomal vulnerability in schizophrenia.
    [Show full text]
  • Dosage Compensation in Mammals: Fine-Tuning the Expression of the X Chromosome
    Downloaded from genesdev.cshlp.org on September 27, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Dosage compensation in mammals: fine-tuning the expression of the X chromosome Edith Heard1,3 and Christine M. Disteche2,4 1CNRS UMR218, Curie Institute, 75248 Paris, Cedex 05, France; 2Department of Pathology and Department of Medicine, University of Washington, Seattle, Washington 98195, USA Mammalian females have two X chromosomes and somes. In eutherians, X-chromosome inactivation (XCI) males have only one. This has led to the evolution of affects the paternal or maternal X chromosome ran- special mechanisms of dosage compensation. The inac- domly during early development, and the inactive state tivation of one X chromosome in females equalizes gene is then stably inherited, giving rise to adults that are expression between the sexes. This process of X-chromo- mosaics for two cell types, expressing one or the other X some inactivation (XCI) is a remarkable example of long- chromosome. The initiation of X inactivation is con- range, monoallelic gene silencing and facultative hetero- trolled by the X-inactivation center (Xic), which pro- chromatin formation, and the questions surrounding it duces the noncoding Xist transcript responsible for trig- have fascinated biologists for decades. How does the in- gering silencing in cis. In marsupials and in the extraem- activation of more than a thousand genes on one X chro- bryonic tissues of some placental mammals such as mosome take place while the other X chromosome, rodents, XCI is imprinted, with the paternal X chromo- present in the same nucleus, remains genetically active? some (Xp) being inactivated.
    [Show full text]
  • Human Tagged ORF Clone – RG212703
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RG212703 Trophinin (TRO) (NM_177556) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: Trophinin (TRO) (NM_177556) Human Tagged ORF Clone Tag: TurboGFP Symbol: TRO Synonyms: MAGE-d3; MAGED3 Vector: pCMV6-AC-GFP (PS100010) E. coli Selection: Ampicillin (100 ug/mL) Cell Selection: Neomycin This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 4 Trophinin (TRO) (NM_177556) Human Tagged ORF Clone – RG212703 ORF Nucleotide >RG212703 representing NM_177556 Sequence: Red=Cloning site Blue=ORF Green=Tags(s) TTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTGGATCCGGTACCGAGGAGATCTGCC GCCGCGATCGCC ATGGATAGGAGAAATGACTACGGATATAGGGTGCCTCTATTTCAGGGCCCTCTGCCTCCCCCGGGGAGCC TGGGGCTTCCCTTCCCTCCAGATATACAGACTGAGACCACAGAAGAGGACAGTGTCCTGCTGATGCATAC CCTGTTGGCGGCAACCAAGGACTCCCTGGCCATGGACCCACCAGTTGTCAACCGGCCTAAGAAAAGCAAG ACCAAGAAGGCCCCTATAAAGACTATTACTAAGGCTGCACCTGCTGCCCCTCCAGTCCCAGCTGCCAATG AGATTGCCACCAACAAGCCCAAAATAACTTGGCAGGCTTTAAACCTGCCAGTCATTACCCAGATCAGCCA GGCTTTACCTACCACTGAGGTAACCAATACTCAGGCTTCTTCAGTCACTGCTCAGCCTAAGAAAGCCAAC AAGATGAAGAGAGTTACTGCCAAGGCAGCCCAAGGCTCCCAATCCCCAACTGGCCATGAGGGTGGCACTA TACAGCTGAAGTCACCCTTGCAGGTCCTAAAGCTACCAGTCATCTCACAGAATATTCACGCTCCAATTGC CAATGAGTCAGCCAGTTCCCAAGCCTTGATAACCTCTATCAAGCCTAAGAAAGCTTCCAAGGCTAAGAAG
    [Show full text]
  • Genetic Technologies for Building a Better Mouse
    Downloaded from genesdev.cshlp.org on September 29, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW A most formidable arsenal: genetic technologies for building a better mouse James F. Clark,1 Colin J. Dinsmore,1 and Philippe Soriano Department of Cell, Developmental, and Regenerative Biology, Icahn School of Medicine at Mt. Sinai, New York, New York 10029, USA The mouse is one of the most widely used model organ- scribing Mendelian inheritance for mouse coat color char- isms for genetic study. The tools available to alter the acteristics (Cuénot 1902). Mendel himself had started mouse genome have developed over the preceding decades down this same road fifty years earlier, only for his bishop from forward screens to gene targeting in stem cells to the to snuff out the nascent breeding program because a monk recent influx of CRISPR approaches. In this review, we had no business, frankly, breeding (Paigen 2003). first consider the history of mice in genetic study, the Following Cuénot’s papers (Cuénot 1902), genetic re- development of classic approaches to genome modifica- search using the mouse began in earnest, often through tion, and how such approaches have been used and im- the study of spontaneous mouse mutants. One line of re- proved in recent years. We then turn to the recent surge search further explored the complicated genetics of pig- of nuclease-mediated techniques and how they are chang- mentation and the sometimes-surprising coincident ing the field of mouse genetics. Finally, we survey com- phenotypes. The Dominant white spotting allele W (an al- mon classes of alleles used in mice and discuss how lele of the receptor tyrosine kinase Kit) was found to affect they might be engineered using different methods.
    [Show full text]
  • Uniprot: a Hub for Protein Information the Uniprot Consortium1,2,3,4,*
    D204–D212 Nucleic Acids Research, 2015, Vol. 43, Database issue Published online 27 October 2014 doi: 10.1093/nar/gku989 UniProt: a hub for protein information The UniProt Consortium1,2,3,4,* 1European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, UK, 2SIB Swiss Institute of Bioinformatics, Centre Medical Universitaire, 1 rue Michel Servet, 1211 Geneva 4, Switzerland, 3Protein Information Resource, Georgetown University Medical Center, 3300 Whitehaven Street North West, Suite 1200, Washington, DC 20007, USA and 4Protein Information Resource, University of Delaware, 15 Innovation Way, Suite 205, Newark, DE 19711, USA Received September 16, 2014; Accepted October 04, 2014 ABSTRACT with high-throughput data and automatic annotation ap- Downloaded from proaches to allow it to be fully exploited. UniProt facilitates UniProt is an important collection of protein se- scientific discovery by organizing biological knowledge and quences and their annotations, which has doubled enabling researchers to rapidly comprehend complex areas in size to 80 million sequences during the past year. of biology. This growth in sequences has prompted an exten- In brief, UniProt is composed of several important sion of UniProt accession number space from 6 to 10 component parts. The section of UniProt that con- http://nar.oxfordjournals.org/ characters. An increasing fraction of new sequences tains manually curated and reviewed entries is known as are identical to a sequence that already exists in UniProtKB/Swiss-Prot and currently contains about half a the database with the majority of sequences coming million sequences. This section grows as new proteins are from genome sequencing projects.
    [Show full text]
  • Uniprot: a Hub for Protein Information the Uniprot Consortium1,2,3,4,*
    D204–D212 Nucleic Acids Research, 2015, Vol. 43, Database issue Published online 27 October 2014 doi: 10.1093/nar/gku989 UniProt: a hub for protein information The UniProt Consortium1,2,3,4,* 1European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, UK, 2SIB Swiss Institute of Bioinformatics, Centre Medical Universitaire, 1 rue Michel Servet, 1211 Geneva 4, Switzerland, 3Protein Information Resource, Georgetown University Medical Center, 3300 Whitehaven Street North West, Suite 1200, Washington, DC 20007, USA and 4Protein Information Resource, University of Delaware, 15 Innovation Way, Suite 205, Newark, DE 19711, USA Received September 16, 2014; Accepted October 04, 2014 Downloaded from ABSTRACT with high-throughput data and automatic annotation ap- proaches to allow it to be fully exploited. UniProt facilitates UniProt is an important collection of protein se- scientific discovery by organizing biological knowledge and quences and their annotations, which has doubled enabling researchers to rapidly comprehend complex areas in size to 80 million sequences during the past year. of biology. This growth in sequences has prompted an exten- In brief, UniProt is composed of several important http://nar.oxfordjournals.org/ sion of UniProt accession number space from 6 to 10 component parts. The section of UniProt that con- characters. An increasing fraction of new sequences tains manually curated and reviewed entries is known as are identical to a sequence that already exists in UniProtKB/Swiss-Prot and currently contains about half a the database with the majority of sequences coming million sequences. This section grows as new proteins are from genome sequencing projects.
    [Show full text]
  • Literature Mining of Transcription Factors Involved In
    Finding biomarkers in non-model species: literature mining of transcription factors involved in bovine embryo development Nicolas Turenne, Evgeniy Tiys, Vladimir Ivanisenko, Nikolay Yudin, Elena Ignatieva, Damien Valour, Severine Degrelle, Isabelle Hue To cite this version: Nicolas Turenne, Evgeniy Tiys, Vladimir Ivanisenko, Nikolay Yudin, Elena Ignatieva, et al.. Finding biomarkers in non-model species: literature mining of transcription factors involved in bovine em- bryo development. BioData Mining, BioMed Central, 2012, 5 (1), pp.12. 10.1186/1756-0381-5-12. inserm-02440326 HAL Id: inserm-02440326 https://www.hal.inserm.fr/inserm-02440326 Submitted on 15 Jan 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Turenne et al. BioData Mining 2012, 5:12 http://www.biodatamining.org/content/5/1/12 BioData Mining METHODOLOGY Open Access Finding biomarkers in non-model species: literature mining of transcription factors involved in bovine embryo development Nicolas Turenne1*†, Evgeniy Tiys2†, Vladimir Ivanisenko2†, Nikolay Yudin5†, Elena Ignatieva6†,
    [Show full text]
  • Reproductive Biology and Endocrinology Biomed Central
    Reproductive Biology and Endocrinology BioMed Central Review Open Access The prolactin and growth hormone families: Pregnancy-specific hormones/cytokines at the maternal-fetal interface Michael J Soares* Address: Institute of Maternal-Fetal Biology, Division of Cancer & Developmental Biology, Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, Kansas 66160, USA Email: Michael J Soares* - [email protected] * Corresponding author Published: 05 July 2004 Received: 05 February 2004 Accepted: 05 July 2004 Reproductive Biology and Endocrinology 2004, 2:51 doi:10.1186/1477-7827-2-51 This article is available from: http://www.rbej.com/content/2/1/51 © 2004 Soares; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. Abstract The prolactin (PRL) and growth hormone (GH) gene families represent species-specific expansions of pregnancy-associated hormones/cytokines. In this review we examine the structure, expression patterns, and biological actions of the pregnancy-specific PRL and GH families. Review their association with pregnancy and regulatory mecha- Prolactin (PRL) and growth hormone (GH) are hor- nisms controlling viviparity. In this minireview we exam- mones/cytokines responsible for the coordination of a ine the structure, expression patterns, and biological wide range of biological processes in vertebrates. They can actions of the PRL and GH families from rodents (prima- act as classic endocrine modulators (hormones) via entry rily rat and mouse), ruminants (primarily ovine and into the circulation or locally (cytokines) through juxta- bovine), and primates (primarily human).
    [Show full text]
  • Trophinin (TRO) (NM 016157) Human Untagged Clone Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for SC314479 Trophinin (TRO) (NM_016157) Human Untagged Clone Product data: Product Type: Expression Plasmids Product Name: Trophinin (TRO) (NM_016157) Human Untagged Clone Tag: Tag Free Symbol: TRO Synonyms: MAGE-d3; MAGED3 Vector: pCMV6 series This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 3 Trophinin (TRO) (NM_016157) Human Untagged Clone – SC314479 Fully Sequenced ORF: >NCBI ORF sequence for NM_016157, the custom clone sequence may differ by one or more nucleotides ATGGATAGGAGAAATGACTACGGATATAGGGTGCCTCTATTTCAGGGCCCTCTGCCTCCC CCGGGGAGCCTGGGGCTTCCCTTCCCTCCAGATATACAGACTGAGACCACAGAAGAGGAC AGTGTCCTGCTGATGCATACCCTGTTGGCGGCAACCAAGGACTCCCTGGCCATGGACCCA CCAGTTGTCAACCGGCCTAAGAAAAGCAAGACCAAGAAGGCCCCTATAAAGACTATTACT AAGGCTGCACCTGCTGCCCCTCCAGTCCCAGCTGCCAATGAGATTGCCACCAACAAGCCC AAAATAACTTGGCAGGCTTTAAACCTGCCAGTCATTACCCAGATCAGCCAGGCTTTACCT ACCACTGAGGTAACCAATACTCAGGCTTCTTCAGTCACTGCTCAGCCTAAGAAAGCCAAC AAGATGAAGAGAGTTACTGCCAAGGCAGCCCAAGGCTCCCAATCCCCAACTGGCCATGAG GGTGGCACTATACAGCTGAAGTCACCCTTGCAGGTCCTAAAGCTACCAGTCATCTCACAG AATATTCACGCTCCAATTGCCAATGAGTCAGCCAGTTCCCAAGCCTTGATAACCTCTATC AAGCCTAAGAAAGCTTCCAAGGCTAAGAAGGCTGCAAATAAGGCCATAGCTAGTGCCACC GAGGTCTCGCTGGCTGCAACTGCCACCCATACAGCTACCACCCAAGGCCAAATTACCAAT
    [Show full text]